MEREO BIOPH. ADR LS-,003
Certificat de dépôt · US5894921072 · MREO · A2PEYJ (LSSI)
2,37 EUR
10.06.2025 17:07
Cours actuels de MEREO BIOPH. ADR LS-,003
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
MREO
|
USD
|
10.06.2025 17:07
|
2,71 USD
| 2,65 USD
+2,08 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
-0,74 % | 2,06 % | 9,80 % | 3,04 % | -34,23 % | -25,49 % | 3,55 % |
Profil de l'entreprise pour MEREO BIOPH. ADR LS-,003 Certificat de dépôt
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was incorporated in 2015 and is based in London, the United Kingdom.
Données de l'entreprise
Nom MEREO BIOPH. ADR LS-,003
Société Mereo BioPharma Group plc
Symbole MREO
Site web
https://www.mereobiopharma.com
Marché d'origine
Lang & Schwarz

WKN A2PEYJ
ISIN US5894921072
Type de titre Certificat de dépôt
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Denise Vera Scots-Knight Ph.D.
Capitalisation boursière 351 Mio
Pays Royaume-Uni
Devise EUR
Employés 0,0 T
Adresse One Cavendish Place, W1G 0QF London
Date d'introduction en bourse 2019-04-24
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | MAH0.F |
NASDAQ | MREO |
Autres actions
Les investisseurs qui détiennent MEREO BIOPH. ADR LS-,003 ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.